StockData
ALCNYSEOphthalmic GoodsFiscal year ends December 31

ALCON INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 24, 2026
$66.13−0.05 (-0.08%)

Close on Oct 19, 2026

Market cap
$32.32B
P/E (TTM)
33.4
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2025
Ended Jun 30, 2025
Aug 19, 2025During market hours$2.60B$0.35$0.76
Q2 FY2024
Ended Jun 30, 2024
Aug 20, 2024During market hours$2.50B$0.45$0.74
Q2 FY2023
Ended Jun 30, 2023
Aug 15, 2023During market hours$2.40B$0.34$0.69
Q4 FY2022
Ended Dec 31, 2022
Feb 27, 2023During market hours–––
Q2 FY2022
Ended Jun 30, 2022
Aug 9, 2022During market hours–––
Q4 FY2021
Ended Dec 31, 2021
Feb 15, 2022During market hours–––

Company guidance

Outlook given with results on Aug 19, 2025, compared with the previous outlook

MeasurePeriodGuidancevs. prior
Core diluted EPSnon-GAAP2025$3.05 to $3.15New
Core operating marginnon-GAAP202519.5% to 20.5%New
Core effective tax ratenon-GAAP202518%New
Non-operating income & expenseGAAP2025$185.00M to $205.00MNew
Change vs. prior year (cc)non-GAAP20254% to 5% growthNew
Net sales (USD)GAAP2025$10.30B to $10.40BNew

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Alcon filed with the SEC